Activities of Maria SPYRAKI related to 2020/0102(COD)
Plenary speeches (1)
Programme for the Union’s action in the field of health for the period 2021-2027 (‘EU4Health programme’) (debate)
Amendments (15)
Amendment 347 #
Proposal for a regulation
Recital 22
Recital 22
(22) The Programme should therefore support actions to monitestablish and support the creation of a central monitoring and early notification mechanism for shortages of medicines, medical devices and other healthcare products and to ensure greater availability and affordability of those products while limiting the dependency of their supply chains on third countries and avoid the fragmentation of the internal market. In particular, in order to address unmet medical needs, the Programme should provide support to clinical trials so as to speed up the development, authorisation and access to innovative and effective medicines, promote incentives to develop such medicinal products as antimicrobials and foster the digitial transformation of healthcare products and platforms for monitoring and collecting information on medicines.
Amendment 606 #
Proposal for a regulation
Article 4 – paragraph 1 – point 10 a (new)
Article 4 – paragraph 1 – point 10 a (new)
(10a) support actions aimed at developing and supporting an EU monitoring and early notification platform for shortages, based on EU harmonised data and national reporting systems;
Amendment 685 #
Proposal for a regulation
Annex I – point c – point iii
Annex I – point c – point iii
(iii) Expert groups and panels providing advice, data and information to support and evaluate health policy development and implementation;
Amendment 692 #
Proposal for a regulation
Annex I – point c – point iv
Annex I – point c – point iv
(iv) Studies and analysis, and scientific advice to support policymaking, and support to the scientific committees on "Consumer Safety" and on "Health, Environmental and Emerging Risks", as well as the Expert Group on "Health Systems Performance Assessment".
Amendment 735 #
Proposal for a regulation
Annex I – point d – point xi a (new)
Annex I – point d – point xi a (new)
(xia) Awareness raising campaigns for the general population as well as targeted groups;
Amendment 758 #
Proposal for a regulation
Annex I – point f – point iii
Annex I – point f – point iii
(iii) Support and/or procure emergency production of medical countermeasures, including essential medicines, chemicals and active substances, and the financing of cooperation on emergency health technology assessments and clinical trials; and secure financing in case of exceptional measures to free capacity of production lines that can be used to provide ICU medicines and equipment;
Amendment 785 #
Proposal for a regulation
Annex I – point f – point viii a (new)
Annex I – point f – point viii a (new)
(viiia) Actions to secure continuity of undisrupted access to medicines, of care and treatment and in particular of chronic conditions during a health crisis;
Amendment 832 #
Proposal for a regulation
Annex I – point g – point xiii a (new)
Annex I – point g – point xiii a (new)
(xiiia) Support the development and implementation of programmes assisting Member States to improve their generic and biosimilar use to increase healthcare system resilience and efficiency;
Amendment 837 #
Proposal for a regulation
Annex I – point g – point xiii b (new)
Annex I – point g – point xiii b (new)
(xiiib) Support the measurement, collection and analysis of patient outcomes, including by expanding the scope of data collection in routine clinical practice in a way that is standardised across the EU;
Amendment 880 #
Proposal for a regulation
Annex I – point h – point v
Annex I – point h – point v
(v) Actions supporting access to cancer services and to innovative and cost- effective medicines for cancer;
Amendment 916 #
Proposal for a regulation
Annex I – point h – point x a (new)
Annex I – point h – point x a (new)
(xa) actions to promote health and safety for healthcare workers involved in cancer treatment;
Amendment 921 #
Proposal for a regulation
Annex I – point h – point x b (new)
Annex I – point h – point x b (new)
(xb) Support to Member States in setting up and implementing up-to-date National Cancer Plans in line with the EU Beating Cancer plan;
Amendment 995 #
Proposal for a regulation
Annex I – point j – point ii
Annex I – point j – point ii
(ii) Support investments in to the digital transformation of health care and health systems, including through benchmarking and capacity building for the uptake of innovative tools and technologies; support investments in infrastructures, digital tools and methodologies to collect and analyse health data and real-world evidence; support digital upskilling of health care professsionals;
Amendment 1017 #
Proposal for a regulation
Annex II – part 1 – point I
Annex II – part 1 – point I
I. Quality and completeness of EU and MS preparedness and response planning for serious cross border threats to health, including harmonized resilience assessment indicators across the EU
Amendment 1059 #
Proposal for a regulation
Annex II – part 2 – point 3
Annex II – part 2 – point 3
3. Number of vaccine doses distributedVaccination coverage rates for all vaccinations included in the national immunization programmes